Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries

Heart and Vessels

Volumn 23, Issue 2, 2008, Pages 83-90

  Ninomiya, Yuichi ^a   Hamasaki, Shuichi ^a   Saihara, Keishi ^a   Ishida, Sanemasa ^a   Kataoka, Tetsuro ^a   Ogawa, Masakazu ^a   Orihara, Koji ^a   Oketani, Naoya ^a   Fukudome, Tsuyoshi ^a   Okui, Hideki ^a   Ichiki, Tomoko ^a   Shinsato, Takuro ^a   Kubozono, Takuro ^a   Mizoguchi, Etsuko ^a   Ichiki, Hitoshi ^a   Tei, Chuwa ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Endothelial function; Nitrates; Shear stress; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; AMLODIPINE BESYLATE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; LONG ACTING DRUG; NICORANDIL; NIFEDIPINE; NITRIC ACID DERIVATIVE; PAPAVERINE;

ADULT; AGED; ANGINA PECTORIS; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENDOTHELIUM CELL; FEMALE; GUIDE WIRE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; MALE; PRIORITY JOURNAL; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ACETYLCHOLINE; AGED; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VASOSPASM; CORONARY VESSELS; FEMALE; HUMANS; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NITRATES; NITROGLYCERIN; PAPAVERINE; SEVERITY OF ILLNESS INDEX; STRESS, MECHANICAL; TREATMENT OUTCOME; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 41849131021     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-007-1019-4     Document Type: Article

References (53)

1. Yusuf S, Collins R, McMahon S, Peto R (1988) Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomized trials. Lancet 1:1088-1092
2. Jugdutt BI (1992) Role of nitrates after acute myocardial infraction. Am J Cardiol 70:82B-87B
3. GISSI-3 (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell-infarto Miocardico. Lancet 343:1115-1122
4. ISIS-4 (1995) A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669-685
5. Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N, Yamamoto T, Nakai S, Hama J, Oyaizu M, Kimura A, Yamamoto K, Aso N, Arai M, Yabushita H, Katori R (1996) Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J 60:779-788
6. Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. (1995) Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci USA 92:5244-5248
7. Zierhut W, Ball HA (1996) Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C. Br J Pharmacol 119:3-5
8. Heitzer T, Just H, Meinertz T, Brockhoff C, Munzel T (1998) Chronic angiotensin converting enzyme inhibition with captopril prevents nitroglycerin induced hypersensitivity to vasoconstrictors in patients with stable coronary artery disease. J Am Coll Cardiol 31:83-88
9. Furberg CD, Psaty BM, Meyer JV (1995) Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 92:1326-1331
10. Thadani U, Glasser S, Bittar N, Beach CI (1994) Dose-response evaluation of once-daily therapy with a new formation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol 74:9-17
11. Gibbs JS, McAlpine HM, Wright C, McLenachan JM, Sparrow J, Sutton G, Dargie HJ, Fox KM (1991) Double-blind randomized placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina. Int J Cardiol 31:281-286
12. Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S; A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators (2004) Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomized controlled trial. Lancet 364:849-857
13. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ; CAMELOT Investigators (2004) Effect of antihypertensive agents on cardiovascular events in patients with coronary diseAse and normal blood pressure: The CAMELOT study: a randomized controlled trial. JAMA 292:2217-2225
14. Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W (2000) Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 102:1503-1510
15. Egashira K (2002) Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J 66(6):529-533
16. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T, Takeshita A (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25(2):201-206
17. Zeiher AM, Schachinger V, Minners J (1995) Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92(5):1094-1100
18. Matsuo T, Iwade K, Hirata N, Yamashita M, Ikegami H, Tanaka N, Aosaki M, Kasanuki H (2005) Improvement of atrial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia. Heart Vessels 20(1):8-12
19. Takagi A, Tsurumi Y, Ishizuka N, Omori H, Arai K, Hagiwara N, Kasanuki H (2006) Single administration of cerivastatin, an HMD-CoA reductase inhibitor, improves the coronary flow velocity reserve: A transthoracic Doppler echocardiography study. Heart Vessels 21(5):298-301
20. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ (1995) Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol 26:41-49
21. Lerman A, Holmes DR Jr., Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr (1995) Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92:2426-2431
22. Hasdai D, Gibbons RJ, Holmes DR Jr., Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96:3390-3395
23. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A (1993) Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88:77-81
24. Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K (2002) Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolemia. Heart 87:264-269
25. Ishida S, Hamasaki S, Kamekou M, Yoshitama T, Nakano F, Yoshikawa A, Kataoka T, Saihara K, Minagoe S, Tei C (2003) Advancing age is associated with diminished vascular remodeling and impaired vasodilation in resistance coronary arteries. Coronary Artery Dis 14:443-449
26. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J (1992) Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 85:1899-1911
27. de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81:107-117
28. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C (1999) Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Am Heart J 138:577-585
29. Moss AJ, Goldstein RE, Hall WJ, Bigger JT Jr., Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ, Benhorin J, Brown MW, Case R, Coromilas J, Dwyer EM Jr., Gillespie JA, Gregory JJ, Kleiger R, Lichstein E, Parker JO, Raubertas RF, Stern S, Tzivoni D, Voorhees LV, for the Multicenter Myocardial Ischemia Group (1993) Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter Myocardial Ischemia Research Group. JAMA 269:2379-2385
30. The Multicenter Diltiazem Post-infarction Trial Group (1988) The effect of diltiazem on mortality and reinfarction after myocardial infraction. N Engl J Med 319:385-392
31. Caramori PR, Adelman AG, Azevedo ER, Newton GE, Parker AB, Parker JD (1998) Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine. J Am Coll Cardiol 32(7):1969-1974
32. Parker JD, Gori T (2001) Tolerance to the organic nitrates: New ideas, new mechanisms, continued mystery. Circulation 104(19):2263-2265
33. Mangione NJ, Glasser SP (1994) Phenomenon of nitrate tolerance. Am Heart J 128:137-146
34. Dupuis J, Lalonde G, Lemieux R, Rouleau JL (1990) Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-Acetylcysteine. J Am Coll Cardiol 16:923-931
35. Keller LH, Hulley SB, Cohen JD, Neaton J (1986) Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: A critical analysis. Circulation 73:114-123
36. Topper JN, Cai J, Falb D, Gimbrone MAJ (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93:10417-10422
37. Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905
38. Chou TC, Yen MH, Li CY, Ding YA (1998) Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31:643-648
39. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146-154
40. Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97:2494-2498
41. Davies PF (1995) Flow-mediated endothelial mechanotransduction. Physiol Rev 75:519-560
42. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G (2000) Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902:230-239
43. Gotlieb AI, Langille BL (1996) The role of rheology in atherosclerotic coronary artery disease. In: Fuster V, Ross R, Topol EJ (eds) Atherosclerosis and coronary artery disease. Lippincott-Raven, Philadelphia, pp 595-606
44. Ben Drias A, Benessiano J, Poitevin P, Levy BI, Michel JB (1997) Arterial expansive remodeling induced by high flow rates. Am J Physiol 272:H851-858
45. Fukaya Y, Ohhashi T (1996) Acetylcholine-and flow-induced production and release of nitric oxide in arterial and venous endothelial cells. Am J Physiol 270:H99-106
46. Griscavage JM, Fukuto JM, Komori Y, Ignarro LJ (1994) Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. J Biol Chem 269:21644-21649
47. Suwaidi J AL, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948-954
48. Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899-1906
49. Zeiher AM, Drexeler H, Wollschlyger H, Just H (1991) Modulation of coronary vascular tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391-401
50. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation: Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68
51. van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaque is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36-44
52. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E (1995) Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 91:2345-2352
53. Beltrame JF, Sasayama S, Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 33:1442-1452